Madrigal Pharmaceuticals
MDGL
MDGL
303 hedge funds and large institutions have $7.13B invested in Madrigal Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 105 increasing their positions, 109 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
303
Holders Change
-14
Holders Change %
-4.42%
% of All Funds
4.06%
Holding in Top 10
12
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
40
Increased
105
Reduced
109
Closed
51
Calls
$294M
Puts
$155M
Net Calls
+$139M
Net Calls Change
-$43.4M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$62.5M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$56.6M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$55.9M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$55.7M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$22.8M |
Top Sellers
| 1 |
Holocene Advisors
New York
|
-$129M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$62.6M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$47.8M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$44.6M |
| 5 |
Morgan Stanley
New York
|
-$41.4M |
